Related references
Note: Only part of the references are listed.Metastasis Suppressors Regulate the Tumor Microenvironment by Blocking Recruitment of Prometastatic Tumor-Associated Macrophages
Casey Frankenberger et al.
CANCER RESEARCH (2015)
PTX3 Is an Extrinsic Oncosuppressor Regulating Complement-Dependent Inflammation in Cancer
Eduardo Bonavita et al.
CELL (2015)
The interaction of anticancer therapies with tumor-associated macrophages
Alberto Mantovani et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2015)
Macrophages are critical effectors of antibody therapies for cancer
Kipp Weiskopf et al.
MABS (2015)
Non-Viral Nanoparticle Delivers Small Interfering RNA to Macrophages In Vitro and In Vivo
Mei Zhang et al.
PLOS ONE (2015)
Carlumab, an anti-C-C chemokine ligand 2 monoclonal antibody, in combination with four chemotherapy regimens for the treatment of patients with solid tumors: an open-label, multicenter phase 1b study
Irene Brana et al.
TARGETED ONCOLOGY (2015)
CSF-1R Expression in Tumor-Associated Macrophages Is Associated With Worse Prognosis in Classical Hodgkin Lymphoma
Young Wha Koh et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2014)
Trabectedin, a drug acting on both cancer cells and the tumour microenvironment
M. D'Incalci et al.
BRITISH JOURNAL OF CANCER (2014)
A Positive Feedback Loop between Mesenchymal-like Cancer Cells and Macrophages Is Essential to Breast Cancer Metastasis
Shicheng Su et al.
CANCER CELL (2014)
Postsurgical Adjuvant Tumor Therapy by Combining Anti-Angiopoietin-2 and Metronomic Chemotherapy Limits Metastatic Growth
Kshitij Srivastava et al.
CANCER CELL (2014)
B Cells Regulate Macrophage Phenotype and Response to Chemotherapy in Squamous Carcinomas
Nesrine I. Affara et al.
CANCER CELL (2014)
Targeting Tumor-Associated Macrophages with Anti-CSF-1R Antibody Reveals a Strategy for Cancer Therapy
Carola H. Ries et al.
CANCER CELL (2014)
The chemokine system, and its CCR5 and CXCR4 receptors, as potential targets for personalized therapy in cancer
Polina Weitzenfeld et al.
CANCER LETTERS (2014)
Tumor Hypoxia Does Not Drive Differentiation of Tumor-Associated Macrophages but Rather Fine-Tunes the M2-like Macrophage Population
Damya Laoui et al.
CANCER RESEARCH (2014)
Inhibition of CSF-1 Receptor Improves the Antitumor Efficacy of Adoptive Cell Transfer Immunotherapy
Stephen Mok et al.
CANCER RESEARCH (2014)
Osteopontin Shapes Immunosuppression in the Metastatic Niche
Sabina Sangaletti et al.
CANCER RESEARCH (2014)
In situ proliferation contributes to accumulation of tumor-associated macrophages in spontaneous mammary tumors
Piotr Tymoszuk et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2014)
Therapeutic potentials of gene silencing by RNA interference: Principles, challenges, and new strategies
Yan Deng et al.
GENE (2014)
Macrophage Activation and Polarization: Nomenclature and Experimental Guidelines
Peter J. Murray et al.
IMMUNITY (2014)
Tumor-Associated Macrophages: From Mechanisms to Therapy
Roy Noy et al.
IMMUNITY (2014)
Transcriptome-Based Network Analysis Reveals a Spectrum Model of Human Macrophage Activation
Jia Xue et al.
IMMUNITY (2014)
Mixed-polarization phenotype of ascites-associated macrophages in human ovarian carcinoma: Correlation of CD163 expression, cytokine levels and early relapse
Silke Reinartz et al.
INTERNATIONAL JOURNAL OF CANCER (2014)
Key role for myeloid cells: Phase II results of anti-GD2 antibody 3F8 plus granulocyte-macrophage colony-stimulating factor for chemoresistant osteomedullary neuroblastoma
Nai-Kong V. Cheung et al.
INTERNATIONAL JOURNAL OF CANCER (2014)
Enhancement of paclitaxel and carboplatin therapies by CCL2 blockade in ovarian cancers
Francois Moisan et al.
MOLECULAR ONCOLOGY (2014)
Functional polarization of tumour-associated macrophages by tumour-derived lactic acid
Oscar R. Colegio et al.
NATURE (2014)
A breast cancer stem cell niche supported by juxtacrine signalling from monocytes and macrophages
Haihui Lu et al.
NATURE CELL BIOLOGY (2014)
Macrophages mediate gemcitabine resistance of pancreatic adenocarcinoma by upregulating cytidine deaminase
N. Weizman et al.
ONCOGENE (2014)
Tracking of intertissue migration reveals the origins of tumor-infiltrating monocytes
Francis H. W. Shand et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
The cellular and molecular origin of tumor-associated macrophages
Ruth A. Franklin et al.
SCIENCE (2014)
Invasive breast carcinoma cells from patients exhibit MenaINV- and macrophage-dependent transendothelial migration
Jeanine Pignatelli et al.
SCIENCE SIGNALING (2014)
Impact of tumour microenvironment and Fc receptors on the activity of immunomodulatory antibodies
Andrew J. S. Furness et al.
TRENDS IN IMMUNOLOGY (2014)
Anti-vascular endothelial growth factor therapy-induced glioma invasion is associated with accumulation of Tie2-expressing monocytes
Konrad Gabrusiewicz et al.
ONCOTARGET (2014)
Classification of current anticancer immunotherapies
Lorenzo Galluzzi et al.
ONCOTARGET (2014)
Depletion of tumor-associated macrophages slows the growth of chemically induced mouse lung adenocarcinomas
Jason M. Fritz et al.
FRONTIERS IN IMMUNOLOGY (2014)
Radiation fosters dose-dependent and chemotherapy-induced immunogenic cell death
Encouse B. Golden et al.
ONCOIMMUNOLOGY (2014)
Neurofibroma-associated macrophages play roles in tumor growth and response to pharmacological inhibition
Carlos E. Prada et al.
ACTA NEUROPATHOLOGICA (2013)
Immunogenic Cell Death in Cancer Therapy
Guido Kroemer et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 31 (2013)
Role of Macrophage Targeting in the Antitumor Activity of Trabectedin
Giovanni Germano et al.
CANCER CELL (2013)
Low-Dose Irradiation Programs Macrophage Differentiation to an iNOS+/M1 Phenotype that Orchestrates Effective T Cell Immunotherapy
Felix Klug et al.
CANCER CELL (2013)
Impeding Macrophage Entry into Hypoxic Tumor Areas by Sema3A/Nrp1 Signaling Blockade Inhibits Angiogenesis and Restores Antitumor Immunity
Andrea Casazza et al.
CANCER CELL (2013)
Macrophage Regulation of Tumor Responses to Anticancer Therapies
Michele De Palma et al.
CANCER CELL (2013)
A first-in-human, first-in-class, phase I study of carlumab (CNTO 888), a human monoclonal antibody against CC-chemokine ligand 2 in patients with solid tumors
Shahneen K. Sandhu et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2013)
Angiopoietin-2 Functions as a Tie2 Agonist in Tumor Models, Where It Limits the Effects of VEGF Inhibition
Christopher Daly et al.
CANCER RESEARCH (2013)
Targeting Tumor-Infiltrating Macrophages Decreases Tumor-Initiating Cells, Relieves Immunosuppression, and Improves Chemotherapeutic Responses
Jonathan B. Mitchem et al.
CANCER RESEARCH (2013)
Chemotherapy Alters Monocyte Differentiation to Favor Generation of Cancer-Supporting M2 Macrophages in the Tumor Microenvironment
Eveline M. Dijkgraaf et al.
CANCER RESEARCH (2013)
CSF1R Signaling Blockade Stanches Tumor-Infiltrating Myeloid Cells and Improves the Efficacy of Radiotherapy in Prostate Cancer
Jingying Xu et al.
CANCER RESEARCH (2013)
A Phase I Study of an Agonist CD40 Monoclonal Antibody (CP-870,893) in Combination with Gemcitabine in Patients with Advanced Pancreatic Ductal Adenocarcinoma
Gregory L. Beatty et al.
CLINICAL CANCER RESEARCH (2013)
Elevated CSF1 serum concentration predicts poor overall survival in women with early breast cancer
Seyedhossein Aharinejad et al.
ENDOCRINE-RELATED CANCER (2013)
Phase 2 study of carlumab (CNTO 888), a human monoclonal antibody against CC-chemokine ligand 2 (CCL2), in metastatic castration-resistant prostate cancer
Kenneth J. Pienta et al.
INVESTIGATIONAL NEW DRUGS (2013)
Fc-dependent depletion of tumor-infiltrating regulatory T cells co-defines the efficacy of anti-CTLA-4 therapy against melanoma
Tyler R. Simpson et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2013)
Macrophage plasticity and polarization in tissue repair and remodelling
Alberto Mantovani et al.
JOURNAL OF PATHOLOGY (2013)
On the Mechanism and Benefit of siRNA-mediated Targeting of CD47 in Cancer
Xiwen Zhao et al.
MOLECULAR THERAPY (2013)
Macrophage biology in development, homeostasis and disease
Thomas A. Wynn et al.
NATURE (2013)
Chemotherapy-triggered cathepsin B release in myeloid-derived suppressor cells activates the Nlrp3 inflammasome and promotes tumor growth
Melanie Bruchard et al.
NATURE MEDICINE (2013)
CSF-1R inhibition alters macrophage polarization and blocks glioma progression
Stephanie M. Pyonteck et al.
NATURE MEDICINE (2013)
Strategies for optimizing the response of cancer and normal tissues to radiation
Everett J. Moding et al.
NATURE REVIEWS DRUG DISCOVERY (2013)
Increase in tumor-associated macrophages after antiangiogenic therapy is associated with poor survival among patients with recurrent glioblastoma
Christine Lu-Emerson et al.
NEURO-ONCOLOGY (2013)
Macrophage Heterogeneity in Respiratory Diseases
Carian E. Boorsma et al.
MEDIATORS OF INFLAMMATION (2013)
Direct Proteomic Quantification of the Secretome of Activated Immune Cells
Felix Meissner et al.
SCIENCE (2013)
Neutralizing Tumor-Promoting Chronic Inflammation: A Magic Bullet?
Lisa M. Coussens et al.
SCIENCE (2013)
Antibody Therapeutics in Cancer
Mark X. Sliwkowski et al.
SCIENCE (2013)
Immunologically augmented cancer treatment using modern radiotherapy
Marco Durante et al.
TRENDS IN MOLECULAR MEDICINE (2013)
Anti-CTLA-4 Antibodies of IgG2a Isotype Enhance Antitumor Activity through Reduction of Intratumoral Regulatory T Cells
Mark J. Selby et al.
CANCER IMMUNOLOGY RESEARCH (2013)
An Abscopal Response to Radiation and Ipilimumab in a Patient with Metastatic Non-Small Cell Lung Cancer
Encouse B. Golden et al.
CANCER IMMUNOLOGY RESEARCH (2013)
Macrophage-tumor cell interactions regulate the function of nitric oxide
Michal A. Rahat et al.
FRONTIERS IN PHYSIOLOGY (2013)
The irradiated tumor microenvironment: role of tumor-associated macrophages in vascular recovery
Jeffery S. Russell et al.
FRONTIERS IN PHYSIOLOGY (2013)
The evolution of the cancer niche during multistage carcinogenesis
Mary Helen Barcellos-Hoff et al.
NATURE REVIEWS CANCER (2013)
Therapeutic applications of macrophage colony-stimulating factor-1 (CSF-1) and antagonists of CSF-1 receptor (CSF-1R) signaling
David A. Hume et al.
BLOOD (2012)
Imaging Tumor-Stroma Interactions during Chemotherapy Reveals Contributions of the Microenvironment to Resistance
Elizabeth S. Nakasone et al.
CANCER CELL (2012)
CCR5 Antagonist Blocks Metastasis of Basal Breast Cancer Cells
Marco Velasco-Velazquez et al.
CANCER RESEARCH (2012)
Targeting monocyte chemotactic protein-1 synthesis with bindarit induces tumor regression in prostate and breast cancer animal models
Massimo Zollo et al.
CLINICAL & EXPERIMENTAL METASTASIS (2012)
Macrophage plasticity and polarization: in vivo veritas
Antonio Sica et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
Deficiency of the macrophage growth factor CSF-1 disrupts pancreatic neuroendocrine tumor development
S. M. Pyonteck et al.
ONCOGENE (2012)
The Distribution of Macrophages with a M1 or M2 Phenotype in Relation to Prognosis and the Molecular Characteristics of Colorectal Cancer
Sofia Edin et al.
PLOS ONE (2012)
Differential macrophage programming in the tumor microenvironment
Brian Ruffell et al.
TRENDS IN IMMUNOLOGY (2012)
The blockade of immune checkpoints in cancer immunotherapy
Drew M. Pardoll
NATURE REVIEWS CANCER (2012)
Cigarette Smoke-Induced Changes to Alveolar Macrophage Phenotype and Function Are Improved by Treatment with Procysteine
Sandra Hodge et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2011)
FcγR2A and 3A polymorphisms predict clinical outcome of trastuzumab in both neoadjuvant and metastatic settings in patients with HER2-positive breast cancer
K. Tamura et al.
ANNALS OF ONCOLOGY (2011)
Transition of tumor-associated macrophages from MHC class IIhi to MHC class IIlow mediates tumor progression in mice
Benfan Wang et al.
BMC IMMUNOLOGY (2011)
Targeting the ANG2/TIE2 Axis Inhibits Tumor Growth and Metastasis by Impairing Angiogenesis and Disabling Rebounds of Proangiogenic Myeloid Cells
Roberta Mazzieri et al.
CANCER CELL (2011)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
Macrophages and cathepsin proteases blunt chemotherapeutic response in breast cancer
Tanaya Shree et al.
GENES & DEVELOPMENT (2011)
TIE2-expressing macrophages limit the therapeutic efficacy of the vascular-disrupting agent combretastatin A4 phosphate in mice
Abigail F. Welford et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Evaluation of Oncology Drugs at the European Medicines Agency and US Food and Drug Administration: When Differences Have an Impact on Clinical Practice
Francesco Trotta et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Successful Colon Cancer Eradication after Chemoimmunotherapy Is Associated with Profound Phenotypic Change of Intratumoral Myeloid Cells
Jose Medina-Echeverz et al.
JOURNAL OF IMMUNOLOGY (2011)
Tumor-associated macrophages regulate tumorigenicity and anticancer drug responses of cancer stem/initiating cells
Masahisa Jinushi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Local Macrophage Proliferation, Rather than Recruitment from the Blood, Is a Signature of TH2 Inflammation
Stephen J. Jenkins et al.
SCIENCE (2011)
Leukocyte Complexity Predicts Breast Cancer Survival and Functionally Regulates Response to Chemotherapy
David G. DeNardo et al.
CANCER DISCOVERY (2011)
Studying the mononuclear phagocyte system in the molecular age
Andrew Chow et al.
NATURE REVIEWS IMMUNOLOGY (2011)
Protective and pathogenic functions of macrophage subsets
Peter J. Murray et al.
NATURE REVIEWS IMMUNOLOGY (2011)
Transcriptional regulation of macrophage polarization: enabling diversity with identity
Toby Lawrence et al.
NATURE REVIEWS IMMUNOLOGY (2011)
Elusive Identities and Overlapping Phenotypes of Proangiogenic Myeloid Cells in Tumors
Seth B. Coffelt et al.
AMERICAN JOURNAL OF PATHOLOGY (2010)
Targeting distinct tumor-infiltrating myeloid cells by inhibiting CSF-1 receptor: combating tumor evasion of antiangiogenic therapy
Saul J. Priceman et al.
BLOOD (2010)
The Therapeutic Effect of Anti-HER2/neu Antibody Depends on Both Innate and Adaptive Immunity
SaeGwang Park et al.
CANCER CELL (2010)
Antitumor and Anti-inflammatory Effects of Trabectedin on Human Myxoid Liposarcoma Cells
Giovanni Germano et al.
CANCER RESEARCH (2010)
Anti-CD47 Antibody Synergizes with Rituximab to Promote Phagocytosis and Eradicate Non-Hodgkin Lymphoma
Mark P. Chao et al.
CELL (2010)
Depletion of Tumor-Associated Macrophages Enhances the Effect of Sorafenib in Metastatic Liver Cancer Models by Antimetastatic and Antiangiogenic Effects
Wei Zhang et al.
CLINICAL CANCER RESEARCH (2010)
A Novel Chemoimmunomodulating Property of Docetaxel: Suppression of Myeloid-Derived Suppressor Cells in Tumor Bearers
Krithika N. Kodumudi et al.
CLINICAL CANCER RESEARCH (2010)
The chemokine system in cancer biology and therapy
Alberto Mantovani et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2010)
Inhibition of STAT3 Signaling Blocks the Anti-apoptotic Activity of IL-6 in Human Liver Cancer Cells
Yan Liu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Bisphosphonates induce apoptosis in mouse macrophage-like cells in vitro by a nitric oxide-independent mechanism
Michael J. Rogers et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2010)
Bisphosphonates in vitro specifically inhibit, among the hematopoietic series, the development of the mouse mononuclear phagocyte lineage
Marco G. Cecchini et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2010)
Inhibition of vasculogenesis, but not angiogenesis, prevents the recurrence of glioblastoma after irradiation in mice
Mitomu Kioi et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
The Tumor-Immune Microenvironment and Response to Radiation Therapy
Stephen L. Shiao et al.
JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA (2010)
A Review of Trabectedin (ET-743): A Unique Mechanism of Action
Maurizio D'Incalci et al.
MOLECULAR CANCER THERAPEUTICS (2010)
Tumor-associated macrophages are predominant carriers of cyclodextrin-based nanoparticles into gliomas
Darya Alizadeh et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2010)
Delivering nanomedicine to solid tumors
Rakesh K. Jain et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2010)
High Expression of Macrophage Colony-Stimulating Factor-1 Receptor in Peritumoral Liver Tissue Is Associated with Poor Outcome in Hepatocellular Carcinoma After Curative Resection
Jin-Bin Jia et al.
ONCOLOGIST (2010)
Inhibition of Mac-1 (CD11b/CD18) enhances tumor response to radiation by reducing myeloid cell recruitment
G-One Ahn et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Macrophages as mediators of tumor immunosurveillance
Siddhartha Jaiswal et al.
TRENDS IN IMMUNOLOGY (2010)
Targeting the tumour vasculature: insights from physiological angiogenesis
Alicia S. Chung et al.
NATURE REVIEWS CANCER (2010)
The Macrophage Colony-Stimulating Factor 1 Response Signature in Breast Carcinoma
Andrew H. Beck et al.
CLINICAL CANCER RESEARCH (2009)
Chemokine (C-C Motif) Ligand 2 Engages CCR2+ Stromal Cells of Monocytic Origin to Promote Breast Cancer Metastasis to Lung and Bone
Xin Lu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Carcinoma-produced factors activate myeloid cells through TLR2 to stimulate metastasis
Sunhwa Kim et al.
NATURE (2009)
The Chemokine CCL2 Increases Prostate Tumor Growth and Bone Metastasis through Macrophage and Osteoclast Recruitment
Kosuke Mizutani et al.
NEOPLASIA (2009)
Granulocyte-macrophage colony-stimulating factor potentiates rituximab in patients with relapsed follicular lymphoma:: Results of a phase II study
Guillaume Cartron et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
High expression of macrophage colony-stimulating factor in peritumoral liver tissue is associated with poor survival after curative resection of hepatocellular carcinoma
Xiao-Dong Zhu et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Re-educating tumor-associated macrophages by targeting NF-κB
Thorsten Hagemann et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2008)
Targeting tumor-associated macrophages in an orthotopic murine model of diffuse malignant mesothelioma
Nathan R. Miselis et al.
MOLECULAR CANCER THERAPEUTICS (2008)
Cancer-related inflammation
Alberto Mantovani et al.
NATURE (2008)
Stromal gene expression predicts clinical outcome in breast cancer
Greg Finak et al.
NATURE MEDICINE (2008)
Stromal Gene Signatures in Large-B-Cell Lymphomas
G. Lenz et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Nitric oxide, apoptosis and macrophage polarization during tumor progression
Andreas Weigert et al.
NITRIC OXIDE-BIOLOGY AND CHEMISTRY (2008)
Modes of resistance to anti-angiogenic therapy
Gabriele Bergers et al.
NATURE REVIEWS CANCER (2008)
A cellular Trojan horse for delivery of therapeutic nanoparticles into tumors
Mi-Ran Choi et al.
NANO LETTERS (2007)
C-Abl is required for the signaling transduction induced by L-selectin ligation
Cuixia Chen et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2007)
Nitric oxide regulates matrix metalloproteinase-9 activity by guanylyl-cyclase-dependent and -independent pathways
Lisa A. Ridnour et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Targeting CCL2 with systemic delivery of neutralizing antibodies induces prostate cancer tumor regression in vivo
Robert D. Loberg et al.
CANCER RESEARCH (2007)
FCGR2A and FCGR3A Polymorphisms associated with clinical outcome of epidermal growth factor receptor expressing metastatic colorectal cancer patients treated with single-agent cetuximab
Wu Zhang et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Targeting tumor-associated macrophages and inhibition of MCP-1 reduce angiogenesis and tumor growth in a human melanoma xenograft
Silvina Gazzaniga et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2007)
Pharmacogenomic analysis of a randomized phase II trial (BOND 2) of cetuximab/bevacizumab/irinotecan (CBI) versus cetuximab/bevacizumab (CB) in irinotecan-refractory colorectal cancer
W. Zhang et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
RNAi therapeutics: Principles, prospects and challenges
Lars Aagaard et al.
ADVANCED DRUG DELIVERY REVIEWS (2007)
Comparative effects of five bisphosphonates on apoptosis of macrophage cells in vitro
M. F. Moreau et al.
BIOCHEMICAL PHARMACOLOGY (2007)
Macrophages regulate the angiogenic switch in a mouse model of breast cancer
Elaine Y. Lin et al.
CANCER RESEARCH (2006)
RNAi therapeutics: a potential new class of pharmaceutical drugs
David Bumcrot et al.
NATURE CHEMICAL BIOLOGY (2006)
Clodronate-liposome-mediated depletion of tumour-associated macrophages:: a new and highly effective antiangiogenic therapy approach
S. M. Zeisberger et al.
BRITISH JOURNAL OF CANCER (2006)
Colony-stimulating factor-1 antibody reverses chemoresistance in human MCF-7 breast cancer xenografts
P Paulus et al.
CANCER RESEARCH (2006)
A new endogenous ATP analog (ApppI) inhibits the mitochondrial adenine nucleotide translocase (ANT) and is responsible for the apoptosis induced by nitrogen-containing bisphosphonates
H Mönkkönen et al.
BRITISH JOURNAL OF PHARMACOLOGY (2006)
TNF-alpha in promotion and progression of cancer
Frances Balkwill
CANCER AND METASTASIS REVIEWS (2006)
Monocyte and macrophage heterogeneity
S Gordon et al.
NATURE REVIEWS IMMUNOLOGY (2005)
Radiation and the microenvironment - Tumorigenesis and therapy
MH Barcellos-Hoff et al.
NATURE REVIEWS CANCER (2005)
Anti-inflammatory properties of the novel antitumor agent yondelis (Trabectedin): Inhibition of macrophage differentiation and cytokine production
P Allavena et al.
CANCER RESEARCH (2005)
Primary antitumor immune response mediated by CD4+ T cells
A Corthay et al.
IMMUNITY (2005)
The chemokine system in diverse forms of macrophage activation and polarization
A Mantovani et al.
TRENDS IN IMMUNOLOGY (2004)
The innate mononuclear phagocyte network depletes B lymphocytes through Fc receptor-dependent mechanisms during anti-CD20 antibody immunotherapy
JJ Uchida et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2004)
Analysis of mannose receptor regulation by IL-4, IL-10, and proteolytic processing using novel monoclonal antibodies
L Martinez-Pomares et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2003)
Interleukin-12 and the regulation of innate resistance and adaptive immunity
G Trinchieri
NATURE REVIEWS IMMUNOLOGY (2003)
Two immunoglobulin G fragment C receptor polymorphisms independently predict response to rituximab in patients with follicular lymphoma
WK Weng et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes
A Mantovani et al.
TRENDS IN IMMUNOLOGY (2002)
Metastasis to bone: Causes, consequences and therapeutic opportunities
GR Mundy
NATURE REVIEWS CANCER (2002)
Colony-stimulating factor 1 promotes progression of mammary tumors to malignancy
EY Lin et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2001)
Share Paper
